Internationally renowned Rutgers University scientist and former director of the Waksman Institute of Microbiology, Joachim Messing, was posthumously honored as this year’s recipient of the Science and Technology Medal from the Research & Development Council of New Jersey for his groundbreaking work in shotgun DNA sequencing.
Rutgers Office for Research has signed an exclusive license with SoftGenetics, LLC for the company to commercialize innovative software technology developed by Rutgers-Camden professors Catherine Grgicak, PhD and Desmond Lun, PhD. The technology, called NOCIt, is a computational tool that calculates the probability of the number of contributors in a DNA profile.
The broad aim of Ngwa’s research and global collaboration is to increase access to cancer treatment and reduce health disparities, particularly in low- and middle-income countries. He leads a research group developing low-cost approaches and technologies that can substantially reduce treatment times and costs and be implemented in resource-poor settings.
Rutgers Office for Research’s Innovation Ventures has executed an exclusive license agreement between the university and Sauvie BiKE, LLC, a subsidiary of Sauvie Inc., to develop and commercialize a bi-specific natural killer cell engager technology in the field of oncology.
Maria Laura ‘Marila’ Gennaro, a professor of medicine at Rutgers New Jersey Medical School and a professor of epidemiology at Rutgers School of Public Health, has been named a National Academy of Inventors Fellow, which is the highest professional distinction accorded solely to academic inventors. The NAI Fellows Program highlights academic inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and the welfare of society.
Much goes into making peaches readily available for New Jersey residents and beyond.
